Researchers at Uppsala University have used AI to develop a new method to study brain cancer. The method […]
With no centralised data collection, it’s hard to know exactly how short staffed general practice is in this […]
“It really hurts,” he said, sipping his beer in his usual languid style. “All those years of staying […]
The number of new covid-19 infections recorded worldwide from 27 December 2021 to 2 January 2022 increased by […]
Two people who had serious diseases but not terminal prognoses have ended their lives legally in Colombia with […]
JPM 2022: How Novavax plans to be a COVID-19 vaccine force in 2022 fkansteiner Tue, 01/11/2022 – 09:31
JPM 2022: Bluebird CEO sees ‘unfinished business’ with Zynteglo in Europe, but scale-up needed first
JPM 2022: Bluebird CEO sees ‘unfinished business’ with Zynteglo in Europe, but scale-up needed first aarmstrong Tue, 01/11/2022 […]
JPM22, Day 2: Teva’s opioid litigation, Roche’s Tecentriq ambitions and more esagonowsky Tue, 01/11/2022 – 08:17
A research team has successfully repurposed an approved drug ifenprodil, a vasodilator, to be used in combination with […]
Helmholtz Munich starts the new year with a triple success: Together with early-career scientists, the research center acquires […]